Molecular Formula | C13H13BrClN3O |
Molar Mass | 342.62 |
Density | 1.645±0.06 g/cm3(Predicted) |
Melting Point | 190-192°C |
Boling Point | 468.4±45.0 °C(Predicted) |
Solubility | Chloroform (Slightly, Sonicated), DMSO (Slightly), Methanol (Slightly, Sonicated |
Appearance | Solid |
Color | White |
pKa | -0.61±0.20(Predicted) |
Storage Condition | under inert gas (nitrogen or Argon) at 2-8°C |
MDL | MFCD13181208 |
Hazard Symbols | T - Toxic |
Risk Codes | 25 - Toxic if swallowed |
Safety Description | 45 - In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) |
UN IDs | UN2811 |
Use | 6-bromo-2-chloro-8-cyclopentyl-5-methyl-pyridino [2,3-D] pyrimidine -7(8H)-ketone is used to prepare pyridino [2,3-d] pyrimidine -7(8H) derivatives, such as CDK4 and/or CDK6 inhibitors, can be used to treat diseases. 6-bromo-2-chloro-8-cyclopentyl-5-methyl-pyridino [2,3-D] pyrimidine -7(8H)-one is a pharmaceutical intermediate and organic synthesis intermediate, which can be used in the laboratory research and development process and the synthesis process of chemical medicine, mainly to synthesize pabxiclib API. |